Vaccines drugs

1 result

Abrysvo (respiratory syncytial virus vaccine)

(Respiratory Syncytial Virus Vaccine)
Pfizer Laboratories Div Pfizer Inc
Usage: ABRYSVO is a vaccine for the active immunization of pregnant individuals (32-36 weeks gestation), individuals 60 years and older, and those aged 18-59 at increased risk, to prevent lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in infants and adults.